Company name | Market Cap | Net Debt | Health score | Current ratio | Quick ratio | Net Debt to FCF | FCF to Interest | Intangibles as % of Total Assets | Total Debt to Equity |
$16.9B | ($182.3M) | 6.2 | 2.8x | 1.9x | (0.7x) | 92.1x | 0.3% | 11.3% | |
$207.3B | ($4,013.3M) | 5.9 | 4.1x | 3.1x | (3.7x) | N/A | 0.1% | 0.0% | |
$66.3B | $17.7B | 6.6 | 9.2x | 3.6x | 6.0x | 11.2x | 0.9% | 55.9% | |
$46.6B | $3,306.0M | 6.7 | 2.8x | 1.7x | 5.4x | 3.2x | 28.3% | 23.8% | |
$34.6B | $317.8M | 6.3 | 3.3x | 1.6x | 0.2x | 64.6x | 0.0% | 16.0% | |
$18.6B | $2,476.1M | 6.1 | 1.9x | 0.8x | 8.6x | 2.3x | 14.5% | 32.0% | |
$17.9B | $11.7B | 5.7 | 1.4x | 0.5x | 20.6x | 1.4x | 20.3% | 191.5% | |
$14.7B | ($1,925.9M) | 6.6 | 3.5x | 2.6x | (1.7x) | 17.3x | 9.1% | 1.0% | |
$10.4B | $550.3M | 5.7 | 2.0x | 1.1x | 3.8x | 3.3x | 3.4% | 69.2% | |
$9,757.8M | $461.9M | 5.9 | 1.4x | 0.8x | 1.3x | 16.5x | 0.0% | 27.7% | |
$8,979.7M | ($111.5M) | 7.2 | 10.4x | 8.4x | (0.8x) | 7.2x | 13.5% | 33.3% |
The West Pharmaceutical Services, Inc. (WST) quick ratio is 1.9x, compared to the industry median of 1.4x and the 5-year historical average of 2.2x.
The West Pharmaceutical Services, Inc. (WST) net debt to FCF ratio is (0.7x), compared to the industry median of 1.3x and the 5-year historical average of ((0.9x)).
West Pharmaceutical Services, Inc. (WST) FCF to interest ratio is 92.1x, compared to the industry median of 3.3x and the 5-year historical average of 50.2x.
The West Pharmaceutical Services, Inc. (WST) total debt to equity ratio is 11.3%, compared to the industry median of 36.3% and the 5-year historical average of 14.2%.